Literature DB >> 10087061

A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic.

R B DeMattos1, F E Thorngate, D L Williams.   

Abstract

Genetic evidence indicates that apolipoprotein E4 (apoE4) is a risk factor for the development of Alzheimer's disease. A controversial hypothesis proposes that apoE, a typical secretory protein, accesses the neuronal cytosol in which apoE3, but not apoE4, protects tau from hyperphosphorylation. However, no conclusive evidence for the presence of apoE in the cytosolic compartment has been presented. We designed a novel assay to test whether apoE can access the cytosol via escape from the endocytic pathway by incorporating a nuclear localization signal (NLS) into apoE. Control experiments demonstrated that apoE plus NLS (apoE+NLS) is chaperoned to the nucleus if it reaches the cytosolic compartment. When exogenous apoE+NLS was endocytosed by neuronal cells, no nuclear apoE was detected, indicating that apoE remains within the endocytic pathway and does not escape into the cytosol. Furthermore, we show that direct cytosolic expression of apoE is cytotoxic. These data argue that effects of apoE on the neuronal cytoskeleton and on neurite outgrowth are not mediated via cytosolic interactions but rather by actions originating at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087061      PMCID: PMC6786055     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

Review 2.  How proteins enter the nucleus.

Authors:  P A Silver
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease.

Authors:  R E Metzger; M J LaDu; J B Pan; G S Getz; D E Frail; M T Falduto
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

4.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.

Authors:  R E Pitas; J K Boyles; S H Lee; D Foss; R W Mahley
Journal:  Biochim Biophys Acta       Date:  1987-01-13

5.  Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study.

Authors:  S H Han; G Einstein; K H Weisgraber; W J Strittmatter; A M Saunders; M Pericak-Vance; A D Roses; D E Schmechel
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

6.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Hepatic expression of genes regulating lipid metabolism in rabbits.

Authors:  T J Rea; R B DeMattos; M E Pape
Journal:  J Lipid Res       Date:  1993-11       Impact factor: 5.922

8.  Apolipoprotein E synthesis in peripheral tissues of nonhuman primates.

Authors:  D L Williams; P A Dawson; T C Newman; L L Rudel
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

9.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Authors:  J K Boyles; R E Pitas; E Wilson; R W Mahley; J M Taylor
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages.

Authors:  I Tabas; J N Myers; T L Innerarity; X X Xu; K Arnold; J Boyles; F R Maxfield
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  14 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration.

Authors:  Haim Belinson; Zehavit Kariv-Inbal; Rakez Kayed; Eliezer Masliah; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 5.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

6.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 7.  Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease.

Authors:  Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 8.  Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.

Authors:  Ronald B DeMattos
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 9.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

10.  Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells.

Authors:  Toshiyuki Nakamura; Atsushi Watanabe; Takahiro Fujino; Takashi Hosono; Makoto Michikawa
Journal:  Mol Neurodegener       Date:  2009-08-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.